- Stocks
- Healthcare
- NYSE: CHE

Price (delayed)

$548.17

Market cap

$8.74B

P/E Ratio

32.25

Dividend/share

$1.32

EPS

$17

Enterprise value

$8.76B

The debt is down by 46% year-on-year and by 6% since the previous quarter

Chemed's quick ratio has increased by 42% from the previous quarter and by 39% YoY

The price to earnings (P/E) is 10% higher than the last 4 quarters average of 29.4 and 9% higher than the 5-year quarterly average of 29.6

What are the main financial stats of CHE

Market
Valuations
Earnings

Shares outstanding

15.95M

Market cap

$8.74B

Enterprise value

$8.76B

Price to earnings (P/E)

32.25

Price to book (P/B)

10.89

Price to sales (P/S)

4.22

EV/EBIT

26.33

EV/EBITDA

22.52

EV/Sales

4.24

Revenue

$2.07B

EBIT

$332.88M

EBITDA

$389.21M

Free cash flow

$410.08M

Per share
Balance sheet
Liquidity

EPS

$17

Free cash flow per share

$25.73

Book value per share

$50.34

Revenue per share

$129.78

TBVPS

$41.91

Total assets

$1.37B

Total liabilities

$565.55M

Debt

$132.55M

Equity

$801.41M

Working capital

-$58.57M

Debt to equity

0.17

Current ratio

0.82

Quick ratio

0.68

Net debt/EBITDA

0.05

Margins
Efficiency
Dividend

EBITDA margin

18.8%

Gross margin

32.8%

Net margin

13.1%

Operating margin

15.7%

Return on assets

20.9%

Return on equity

36.6%

Return on invested capital

72.1%

Return on capital employed

32.1%

Return on sales

16.1%

Dividend yield

0.24%

DPS

$1.32

Payout ratio

7.8%

How has the Chemed stock price performed over time

Intraday

0.54%

1 week

3.58%

1 month

3.04%

1 year

14.13%

YTD

2.92%

QTD

2.92%

How have Chemed's revenue and profit performed over time

Revenue

$2.07B

Gross profit

$678.12M

Operating income

$323.88M

Net income

$271.29M

Gross margin

32.8%

Net margin

13.1%

Chemed's operating income has increased by 31% YoY and by 3% from the previous quarter

The net income has grown by 30% year-on-year and by 3.3% since the previous quarter

The operating margin has increased by 19% YoY

The net margin is up by 18% year-on-year

What is Chemed's growth rate over time

What is Chemed stock price valuation

P/E

32.25

P/B

10.89

P/S

4.22

EV/EBIT

26.33

EV/EBITDA

22.52

EV/Sales

4.24

The EPS has increased by 30% YoY and by 3.4% from the previous quarter

The price to earnings (P/E) is 10% higher than the last 4 quarters average of 29.4 and 9% higher than the 5-year quarterly average of 29.6

The P/B is 40% more than the 5-year quarterly average of 7.8 and 12% more than the last 4 quarters average of 9.7

Chemed's equity has increased by 19% YoY and by 7% from the previous quarter

CHE's P/S is 62% above its 5-year quarterly average of 2.6 and 17% above its last 4 quarters average of 3.6

The revenue rose by 10% year-on-year and by 2.4% since the previous quarter

How efficient is Chemed business performance

The company's return on invested capital rose by 26% YoY and by 13% QoQ

The ROS has increased by 21% YoY

The ROA rose by 9% year-on-year

The ROE has grown by 8% YoY

What is CHE's dividend history

DPS

$1.32

Dividend yield

0.24%

Payout ratio

7.8%

Recent dividends

How did Chemed financials performed over time

Chemed's total assets is 142% higher than its total liabilities

Chemed's quick ratio has increased by 42% from the previous quarter and by 39% YoY

CHE's current ratio is up by 39% from the previous quarter and by 22% YoY

The debt is 83% smaller than the equity

CHE's debt to equity has dropped by 54% year-on-year and by 11% since the previous quarter

The debt is down by 46% year-on-year and by 6% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.